Record
stringlengths 1
197k
|
|---|
* complete two questionnaires before and after the HOBSCOTCH-PD sessions about their quality of life and about memory and thinking processes |
* keep a short daily diary about their PD symptoms and use of the self-management strategies taught in the HOBSCOTCH-PD program |
* complete a brief Satisfaction Survey after the entire HOBSCOTCH-PD program conditions: Parkinson Disease conditions: Cognitive Dysfunction conditions: Memory Disorders studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: OTHER masking: NONE count: 5 type: ESTIMATED name: HOme-Based Self-management and COgnitive Training CHanges lives (HOBSCOTCH) measure: Change in quality of life as measured by comparing PDQ-39 (Parkinson's Disease Questionnaire) scores pre- and post-HOBSCOTCH-PD intervention. measure: Change in subjective cognition as measured by comparing Neuro-QOL Item Bank v2.0 Cognitive Function scores pre- and post-HOBSCOTCH-PD intervention. sex: ALL minimumAge: 30 Years maximumAge: 75 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Dartmouth-Hitchcock status: RECRUITING city: Lebanon state: New Hampshire zip: 03756 country: United States name: Sarah J Kaden role: CONTACT phone: 603-540-5824 email: sarah.j.kaden@hitchcock.org lat: 43.64229 lon: -72.25176 hasResults: False |
<|newrecord|> nctId: NCT06260215 id: FFH briefTitle: Recovery Kinetics Following a Soccer Training in Middle-aged Males overallStatus: RECRUITING date: 2024-02-05 date: 2024-02-26 date: 2024-03-09 date: 2024-02-15 date: 2024-02-21 name: University of Thessaly class: OTHER briefSummary: This study aims at investigating the recovery kinetics of skeletal muscle damage, neuromuscular fatigue and performance following a single soccer trainning session in middle aged males. The participants will perform a soccer training session \[A single training session including 60 minutes of warm up, soccer technical exercises and small-sided game\] and a cotrol trial (No intervention included, only daily measurements) in randomized, repeated measures, crossover design. Assesesments related to skeletal muscle damage, performance and neuromuscular fatigue will be executed before the training session and daily for four consecutive days after training. conditions: Skeletal Muscle Damage studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: CROSSOVER primaryPurpose: OTHER masking: NONE count: 11 type: ESTIMATED name: ST measure: Change in White blood cell count measure: Change in Granulocyte cell count measure: Change in Platelets cell count measure: Change in Monocyte cell count measure: Change in Lymphocyte cell count measure: Change in percentage of Hematocrit level measure: Change Red blood cells count measure: Change in Hemoglobin level measure: Change in Creatine kinase activity measure: Change in Total antioxidant capacity measure: Change in Glutathione concentration in blood measure: Change in countermovement jump height measure: Change in Peak power during coutermovement jump test measure: Change in isometric peak torque of knee extensors and flexors measure: Change in sprint time of 10 m measure: Change in sprint time of 30 m measure: Change in delayed onset of muscle soreness measure: Dietary intake measure: Peak Maximal oxygen consumption (Peak VO2) measure: Body Mass measure: Body Height measure: Body Fat measure: Lean body mass measure: Bone mass density measure: Bone mass content measure: Field activity during the soccer training measure: Heart rate during the soccer training measure: Systolic Blood Pressure measure: Dystolic Blood Pressure measure: Rest Heart Rate sex: MALE minimumAge: 40 Years maximumAge: 60 Years stdAges: ADULT facility: University o Thessaly, School of Physical Education and Sports Science status: RECRUITING city: Tríkala zip: 42100 country: Greece name: Athanasios Z Jamurtas, Prof role: CONTACT phone: +30 24310 47054 email: ajamurt@pe.uth.gr name: Ioannis G Fatouros, Prof role: CONTACT phone: +30 24310 47047 email: ifatouros@pe.uth.gr name: Athanasios S Poulios, PhD role: PRINCIPAL_INVESTIGATOR lat: 39.55493 lon: 21.76837 hasResults: False |
<|newrecord|> nctId: NCT06260202 id: 308.273 briefTitle: Nutrition Under Noninvasive Ventilation acronym: NUTRINIV overallStatus: NOT_YET_RECRUITING date: 2024-03-01 date: 2024-05-31 date: 2024-05-31 date: 2024-02-15 date: 2024-02-16 name: Università degli Studi del Piemonte Orientale "Amedeo Avogadro" class: OTHER briefSummary: Even though nutrition is a fundamental component of Intensive care unit (ICU) therapy, critically ill patients are frequently malnourished, a factor well known for its strong association with a higher risk of complications, prolonged ICU/hospital length of stay, and greater ICU readmission and mortality rates. Noninvasive ventilation (NIV) use has increased considerably over the past twenty years, making this supportive technique a keystone of acute respiratory failure (ARF) treatment. In this setting, respiratory support is provided through an interface, usually a mask or a helmet, that frequently represents an important obstacle to nutrition delivery, making oral intake impossible and posing the necessity to start enteral (EN) or parenteral nutrition (PN). Moreover, while critical care guidelines regarding nutritional management of patients receiving mechanical ventilation (MV) are well established, data and recommendations about the appropriate nutritional support to patients in NIV are still very limited. Due to this limited data, we want to describe characteristics and nutritional management of patients undergoing NIV in ICU, and to evaluate the difference between the mean caloric and protein intake of these patients and the recommended caloric and protein target for critically ill patients. Secondarily, we want to evaluate the difference of the caloric and protein intake among groups of patients undergoing different nutritional modality and to assess potential associations of the nutritional characteristics with patient outcomes. conditions: Noninvasive Ventilation conditions: Nutrition Therapy conditions: Respiratory Insufficiency studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: RETROSPECTIVE count: 112 type: ESTIMATED measure: Caloric and protein gap measure: Nutrition modalities outcomes sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False |
<|newrecord|> nctId: NCT06260189 id: Soh-Med-24-01-02MD briefTitle: Assessment Of Serum And Tissue Levels Of Cold-Inducible RNA-Binding Protein In Patients With Lichen Planus overallStatus: RECRUITING date: 2024-02 date: 2025-02 date: 2025-10 date: 2024-02-15 date: 2024-02-15 name: Sohag University class: OTHER briefSummary: Lichen planus (LP) is a chronic inflammatory mucocutaneous disease of unknown etiology. |
Pathogenesis of LP is not completely understood, but it's considered a T-cell-mediated autoimmune disease. Cold-inducible RNA binding protein (CIRP or CIRBP) is a member of the glycine-rich RNA-binding protein family, Recent studies proved that CIRP acts as a tumor promoter through its actions on different cellular proliferation levels, Recently, the role of the damage associated molecular proteins and cytokines was highlighted in the pathogenesis of many disorders including psoriasis, alopecia areata, vitiligo, rheumatoid arthritis, other autoimmune diseases as well as several types of cancer. The aim of this study is to compare serum and tissue levels of CIRP in patients with LP and healthy controls. conditions: Assessment, Self studyType: OBSERVATIONAL observationalModel: CASE_CONTROL timePerspective: CROSS_SECTIONAL count: 80 type: ESTIMATED measure: Assessment of cold-inducible RNA binding protein levels in serum and tissue sex: ALL minimumAge: 18 Years maximumAge: 60 Years stdAges: ADULT facility: Aya Ahmed Elsayed status: RECRUITING city: Sohag zip: 82511 country: Egypt name: Aya A Elsayed, Msc role: CONTACT phone: 00201060094631 phoneExt: Egypt email: aya_shando@yahoo.com lat: 26.55695 lon: 31.69478 hasResults: False |
<|newrecord|> nctId: NCT06260176 id: 828722 id: R01DK113307 type: NIH link: https://reporter.nih.gov/quickSearch/R01DK113307 id: 15163 type: REGISTRY domain: AsPredicted.org briefTitle: Vending Labeling Sales and Intercepts Study overallStatus: COMPLETED date: 2019-02-01 date: 2020-03-12 date: 2020-03-12 date: 2024-02-15 date: 2024-02-15 name: University of Pennsylvania class: OTHER name: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) briefSummary: The aim of this study is to compare the impact of 4 different types of front of package (FOP) food and beverage messages: 1) green labels on healthy foods, 2) red/yellow/green labels on less healthy/moderately healthy/healthy foods, 3) physical activity calorie equivalent labels, and 4) posters reminding consumers of the sweetened beverage tax on consumers' beverage and snack selections. conditions: Food Preferences conditions: Obesity conditions: Weight Gain studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Machine locations were randomly assigned to 1 of 4 front-of-package message arms, stratified by baseline machine sales (high/low) and type of machine location (correctional facilities, courts/offices, large offices, police/fire, recreation centers/libraries/other) with equal probability. The investigators first randomized vending locations (e.g., floors) with beverage machines so that all machines on the same floor displayed the same label. They then randomized the remaining "solo" snack locations. Monthly sales data provided by the City's vending contractor indicated consumer choices. Research assistants also asked a subset of consumers (N=1,065) about their purchases. Intercepts were not allowed in the courts/offices location type and were not conducted at correctional facilities with low traffic. The aim was to collect 10 intercepts per machine visited, distributed over the entire study period, however the study was cut short in March 2020 by the Covid pandemic. primaryPurpose: PREVENTION masking: NONE count: 1065 type: ACTUAL name: exposure to healthy labels only name: exposure to healthiness information name: exposure to physical activity equivalents name: exposure to sweetened beverage tax messaging measure: Percentage of beverages sold with calories per month measure: Calories sold from beverages per month, if beverages with calories sold measure: Calories sold from snacks per month measure: Likelihood of selecting a healthy beverage measure: Likelihood of selecting a moderately healthy beverage measure: Likelihood of selecting a less healthy beverage measure: Likelihood of selecting a healthy snack measure: Likelihood of selecting a moderately healthy snack measure: Likelihood of selecting a less healthy snack measure: Total beverage units sold per month per machine. measure: Total snack units sold per month per machine measure: Total revenue per month per beverage machine measure: Total revenue per month per snack machine measure: Total calories sold per customer trip sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: University of Pennsylvania city: Philadelphia state: Pennsylvania zip: 19104 country: United States lat: 39.95233 lon: -75.16379 hasResults: False |
<|newrecord|> nctId: NCT06260163 id: CR109251 id: 2022-001285-35 type: EUDRACT_NUMBER id: CNTO1959PUC3001 type: OTHER domain: Janssen Research & Development, LLC id: 2022-502238-22-00 type: REGISTRY domain: EUCT number briefTitle: A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis acronym: QUASAR Jr overallStatus: RECRUITING date: 2024-01-19 date: 2028-05-22 date: 2028-08-14 date: 2024-02-15 date: 2024-04-24 name: Janssen Research & Development, LLC class: INDUSTRY briefSummary: The purpose of this study is to evaluate the efficacy of guselkumab in pediatric participants with moderately to severely active ulcerative colitis at the end of maintenance therapy among participants who were induction responders. conditions: Colitis, Ulcerative studyType: INTERVENTIONAL phases: PHASE3 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: DOUBLE whoMasked: PARTICIPANT whoMasked: INVESTIGATOR count: 120 type: ESTIMATED name: Guselkumab Subcutaneous name: Matching Placebo name: Guselkumab Intravenous measure: Percentage of Participants with Clinical Remission at Week 56 measure: Percentage of Participants with Clinical Remission at Week 12 measure: Percentage of Participants With Pediatric Ulcerative Colitis Activity Index (PUCAI) Remission at Week 12 measure: Percentage of Participants with Symptomatic Remission at Week 12 measure: United States: Percentage of Participants with Endoscopic Improvement at Week 12 measure: European Union: Percentage of Participants with Endoscopic Healing at Week 12 measure: Percentage of Participants with Clinical Response at Week 12 measure: Percentage of Participants with Symptomatic Remission at Week 56 measure: United States: Percentage of Participants With Endoscopic Improvement at Week 56 measure: European Union: Percentage of Participants With Endoscopic Healing at Week 56 measure: Percentage of Participants with Corticosteroid-free Clinical Remission at Week 56 measure: Percentage of Participants with Clinical Response at Week 56 measure: Percentage of Participants Histo-endoscopic Mucosal Improvement at Week 56 measure: Percentage of Participants with Symptomatic Remission at Week 56 Among Participants who had Symptomatic Remission at Week 12 measure: Percentage of Participants Who Achieve Endoscopic Normalization at Week 56 measure: Percentage of Participants With PUCAI Remission at Week 56 measure: Serum Concentration of Guselkumab During Induction Phase measure: Serum Concentration of Guselkumab During Maintenance Phase measure: Number of Participants with Incidence of Anti-guselkumab Antibodies measure: Percentage of Participants with Adverse Events (AEs) measure: Percentage of Participants with Serious Adverse Events (SAEs) measure: Percentage of Participants with AEs Leading to Discontinuation of Study Intervention sex: ALL minimumAge: 2 Years maximumAge: 17 Years stdAges: CHILD facility: Riley Hospital for Children status: RECRUITING city: Indianapolis state: Indiana zip: 46202 country: United States lat: 39.76838 lon: -86.15804 facility: UZ Gent status: RECRUITING city: Gent zip: 9000 country: Belgium lat: 51.05 lon: 3.71667 facility: UZ Brussel status: RECRUITING city: Jette zip: 1090 country: Belgium lat: 50.87309 lon: 4.33419 facility: Capital Institute of Pediatrics status: RECRUITING city: Beijing zip: 100020 country: China lat: 39.9075 lon: 116.39723 facility: Peking University Third Hospital status: RECRUITING city: Beijing zip: 100191 country: China lat: 39.9075 lon: 116.39723 facility: Changzhou No 2 Peoples Hospital status: RECRUITING city: Changzhou City zip: 213004 country: China facility: The Childrens Hospital Zhejiang University School Of Medicine status: RECRUITING city: Hangzhou zip: 310005 country: China lat: 30.29365 lon: 120.16142 facility: Sir Run Run Shaw Hospital, Zhejiang University School of Medicine status: RECRUITING city: Hangzhou zip: 310016 country: China lat: 30.29365 lon: 120.16142 facility: Ruijin Hospital, Shanghai Jiao Tong University status: RECRUITING city: Shanghai zip: 200025 country: China lat: 31.22222 lon: 121.45806 facility: Shengjing Hospital of China Medical University status: RECRUITING city: Shenyang zip: 110004 country: China lat: 41.79222 lon: 123.43278 facility: Hvidovre Hospital status: RECRUITING city: Hvidovre zip: 2650 country: Denmark lat: 55.65719 lon: 12.47364 facility: AOU Policlinico Umberto I status: RECRUITING city: Roma zip: 00161 country: Italy lat: 41.89193 lon: 12.51133 facility: Kanazawa University Hospital status: RECRUITING city: Kanazawa zip: 920-8641 country: Japan lat: 36.6 lon: 136.61667 facility: Kobe University Hospital status: RECRUITING city: Kobe zip: 650-0017 country: Japan lat: 34.6913 lon: 135.183 facility: Japanese Red Cross Kumamoto Hospital status: RECRUITING city: Kumamoto zip: 861-8520 country: Japan lat: 32.80589 lon: 130.69182 facility: Shinshu University Hospital status: RECRUITING city: Matsumoto zip: 390-8621 country: Japan lat: 36.23333 lon: 137.96667 facility: Saga University Hospital status: RECRUITING city: Saga zip: 849-8501 country: Japan lat: 33.23333 lon: 130.3 facility: Tokyo Medical University Hospital status: RECRUITING city: Shinjuku zip: 160-0023 country: Japan lat: 35.2946 lon: 139.57059 facility: Osaka Medical and Pharmaceutical University Hospital status: RECRUITING city: Takatsuki zip: 569-8686 country: Japan lat: 34.84833 lon: 135.61678 facility: Saiseikai Yokohamashi Tobu Hospital status: RECRUITING city: Yokohama zip: 230-8765 country: Japan lat: 35.43333 lon: 139.65 facility: Korczowski Bartosz Gabinet Lekarski status: RECRUITING city: Rzeszow zip: 35-302 country: Poland lat: 50.04132 lon: 21.99901 facility: Medical Network Spolka z o.o. WIP Warsaw IBD Point Profesor Kierkus status: RECRUITING city: Warszawa zip: 04 501 country: Poland lat: 52.22977 lon: 21.01178 facility: Instytut Pomnik Centrum Zdrowia Dziecka status: RECRUITING city: Warszawa zip: 04 730 country: Poland lat: 52.22977 lon: 21.01178 facility: Gazi University Medical Faculty status: RECRUITING city: Ankara zip: 06560 country: Turkey lat: 39.91987 lon: 32.85427 hasResults: False |
<|newrecord|> nctId: NCT06260150 id: ZXT briefTitle: Application of IPC During Surgery to Prevent Venous Thrombosis in Gastrointestinal Surgery Patients. overallStatus: ACTIVE_NOT_RECRUITING date: 2023-04-01 date: 2024-04 date: 2024-04 date: 2024-02-15 date: 2024-02-15 name: Feng Tian class: OTHER_GOV briefSummary: The goal of this clinical trial is to evaluate the effectiveness of intraoperative intermittent pneumatic compression (IPC) device usage in preventing lower extremity deep vein thrombosis (DVT) in patients undergoing gastrointestinal surgery.The main question it aims to answer is provide a reference basis for determining the efficacy of IPC application during gastrointestinal surgery for preventing lower extremity DVT in patients. |
Participants are patients who require gastrointestinal surgery, specifically for the resection of gastrointestinal tumors. They will be divided into a control group and an experimental group. The experimental group will use an Intermittent Pneumatic Compression (IPC) device during surgery, while the control group will receive standard treatment. The objective is to observe whether the use of IPC during surgery can prevent the formation of Deep Vein Thrombosis (DVT) or lower the Risk of DVT. conditions: Gastrointestinal Neoplasms conditions: Stomach Neoplasms conditions: Intestinal Neoplasms studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: PREVENTION masking: QUADRUPLE whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 120 type: ESTIMATED name: Intermittent Pneumatic Compression Devices measure: Incidence rate of DVT measure: Length of surgery measure: Intraoperative body temperature measure: Amount of bleeding during surgery sex: ALL minimumAge: 18 Years maximumAge: 99 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Shandong Provincial Hospital city: Jinan state: Shandong zip: 250021 country: China lat: 36.66833 lon: 116.99722 hasResults: False |
<|newrecord|> nctId: NCT06260137 id: UludagThorax briefTitle: Comparison of Two Different Methods for Reducing Pain After Lung Surgery overallStatus: ACTIVE_NOT_RECRUITING date: 2023-07-10 date: 2024-07 date: 2024-08 date: 2024-02-15 date: 2024-02-15 name: Uludag University class: OTHER briefSummary: The goal of this clinical study is to compare the effectiveness of the Rhomboid Intercostal Block and Sub-Servitus plan block and the effectiveness of the Rhomboid intercostal block in patients with video-supported thoracoscopic surgery. The main question it aims to answer is: |
Which of these two blocks more effectively reduces the patients' pain? conditions: Postoperative Analgesia studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: OTHER masking: SINGLE whoMasked: PARTICIPANT count: 60 type: ESTIMATED name: Rhomboid intercostal block name: Rhomboid intercostal and subserratus plane block measure: Postoperative analgesia sex: ALL minimumAge: 18 Years maximumAge: 80 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Hastane city: Bursa zip: 16210 country: Turkey lat: 40.19559 lon: 29.06013 hasResults: False |
<|newrecord|> nctId: NCT06260124 id: Greek Dancing-UTH briefTitle: Acute Physiological Effects of Greek Traditional Dancing overallStatus: NOT_YET_RECRUITING date: 2024-04-10 date: 2024-06-30 date: 2024-10-30 date: 2024-02-15 date: 2024-04-09 name: University of Thessaly class: OTHER briefSummary: In Greece, people of different age groups, including young children to older adults, are involved in traditional dance. To date, the well-know benefits of dancing include entertainment, socialization and increased physical activity. However, the acute effects of Greek traditional dancing on health, physical performance and muscle damage indices remain largely unknown. Therefore, the aim of this project is to evaluate the acute effect of Greek traditional dancing on health-, physical performance-, and muscle damage-related parameters by considering the impact of dancing tempo (slow vs moderate vs fast). In a crossover repeated measures design 10 pre- and 10 post-menopausal women will participate in the three dancing sessions of different tempo in a random order. conditions: Menopause conditions: Cardiovascular Health conditions: Body Composition conditions: Physical Performance conditions: Muscle Damage studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: CROSSOVER primaryPurpose: BASIC_SCIENCE masking: NONE count: 20 type: ESTIMATED name: Slow tempo name: Moderate tempo name: Fast tempo measure: Change in blood pressure measure: Change in perceived exertion measure: Change in blood lactate measure: Change in resting metabolic rate measure: Change in delayed-onset of muscle soreness (DOMS) measure: Change in maximal isometric voluntary contraction measure: Change in joint range of motion measure: Change in functional performance measure: Change in white blood cell count measure: Change in granulocyte count measure: Change in lymphocytes measure: Change in monocytes measure: Change in creatine kinase concentration measure: Change in reduced glutathione measure: Change in oxidized glutathione measure: Change in catalase activity measure: Change in protein carbonyls measure: Change in total antioxidant capacity measure: Change in heart rate measure: Change in oxygen consumption measure: Change in physical activity measure: Change in red blood cell count measure: Change in hematocrit measure: Change in hemoglobin sex: FEMALE minimumAge: 20 Years maximumAge: 80 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False |
<|newrecord|> nctId: NCT06260111 id: SA23I0021 briefTitle: Photobiomodulation for Oral Mucositis and Functional Impairments During Hematopoietic Stem Cell Transplantation acronym: POMFITT overallStatus: NOT_YET_RECRUITING date: 2024-04-10 date: 2025-10-30 date: 2025-10-30 date: 2024-02-15 date: 2024-02-15 name: Universidad del Desarrollo class: OTHER name: Agencia Nacional de Investigación y Desarrollo name: Clínica Dávila briefSummary: The goal of this clinical trial is to test the efficacy of laser photobiomodulation in adult hematologic cancer patients undergoing hematopoietic stem cell transplantation (HSCT). The main questions it aims to answer are: • Is photobiomodulation with laser in the oral cavity, compared to standard care, effective in preventing oral mucositis and functional impairments in adult patients receiving HSCT? • What is the level of patient´s acceptability of photobiomodulation with laser in the oral cavity during HSCT? Participants once a day will receive photobiomodulation (diode laser device) in their oral cavity from the first day of transplantation conditioning until third day post-transplant. Researchers will compare with usual care to see if photobiomodulation helps preventing oral mucositis and functional impairment. conditions: Hematologic Cancer studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: The design of the study consists of a randomized, controlled trial with parallel groups (photobiomodulation + usual care versus a control group with only usual care), allocation ratio of 1:1. primaryPurpose: PREVENTION masking: DOUBLE maskingDescription: Assessor will be blinded only for the secondary outcomes. The person responsible for statistical analyses will also be blinded. whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 30 type: ESTIMATED name: Photobiomodulation name: Usual care measure: Oral Mucositis measure: Level of Pain measure: Handgrip strength measure: Exercise tolerance measure: Physical fitness measure: Health related quality of life measure: Length of hospital stay measure: Use of opioids measure: Body mass index measure: Nutritional status measure: Daily calorie intake measure: Arm circumference measure: Triceps skinfold sex: ALL minimumAge: 18 Years maximumAge: 70 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Clinica Dávila city: Santiago state: Metropolitana zip: 8431657 country: Chile name: Tomás A López-Espinoza, MSc.C. role: CONTACT phone: +56962056755 email: tlopeze@udd.cl name: Hernán López, MD role: CONTACT phone: +56966795985 email: hernan.lopez@davila.cl name: Monica Peña, Nurse role: SUB_INVESTIGATOR lat: -33.45694 lon: -70.64827 hasResults: False |
<|newrecord|> nctId: NCT06260098 id: H23-0617 briefTitle: StressLess Yoga Study overallStatus: RECRUITING date: 2024-04-03 date: 2024-05-30 date: 2024-05-30 date: 2024-02-15 date: 2024-04-05 name: University of Connecticut class: OTHER briefSummary: The purpose of this study is to assess the feasibility and acceptability of using an asynchronous online yoga program to reduce stress. The study will use an 8 week asynchronous yoga intervention of two different types of yoga (high in breath work and meditation; low in vigorous movement/postures vs. low breath work and meditation; high movement/postures). In addition to self-report stress, measures include sleep, heart rate variability, mindfulness, Essential Properties of Yoga, and acceptability questions. conditions: Stress studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: SINGLE whoMasked: PARTICIPANT count: 40 type: ESTIMATED name: Yoga with High Breath work & meditation; Low movement/postures name: Yoga with Low Breath work & meditation; High movement/postures measure: The number (percentage)of people completing the whole protocol (6/8 yoga classes & 2 in-person visits) measure: The combined score (out of 35) on the 5-item Treatment Acceptability Questionnaire (TAQ) sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Bousfield Psychology Building, 406 Babbidge Road status: RECRUITING city: Storrs state: Connecticut zip: 06269 country: United States name: Crystal Park, PhD role: CONTACT phone: 860-486-3520 email: crystal.park@uconn.edu name: Crystal Park, PhD role: PRINCIPAL_INVESTIGATOR lat: 41.80843 lon: -72.24952 hasResults: False |
<|newrecord|> nctId: NCT06260085 id: 686 briefTitle: Effect of Listening to Relatives' Voice Recordings on Chest Pain, Anxiety, and Depression in Coronary ICU Patients overallStatus: COMPLETED date: 2022-06-04 date: 2023-07-04 date: 2023-09-04 date: 2024-02-15 date: 2024-02-15 name: T.C. ORDU ÜNİVERSİTESİ class: OTHER briefSummary: The aim of the study was to evaluate the effect of listening to the voice recordings of relatives of patients with acute myocardial infarction (AMI) who were treated in the coronary intensive care unit on chest pain, anxiety and depression parameters of the patients. |
Methods In the study, which was conducted as a randomised, controlled, experimental study, voice recordings of the family members of the patients were created and played to the patients through a music pillow. The study was carried out with 60 patients, 30 experimental and 30 control groups. Three tests were applied to the patients 15 minutes before, 15 and 30 minutes after the application. The data of the study were collected using the "Patient Introduction Form", "Hospital Anxiety Depression Scale", "Visual Analogue Scale" and "Patient Follow-up Form". conditions: Acute Myocardial Infarction conditions: Intensive Care Unit Syndrome studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: PREVENTION masking: SINGLE maskingDescription: The clinical nurse collected the data whoMasked: OUTCOMES_ASSESSOR count: 60 type: ACTUAL name: Relatives vioce record measure: Chest Pain measure: Anxiety, and Depression sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Yasemin Kalkan Uğurlu city: Ordu zip: 52200 country: Turkey lat: 40.97782 lon: 37.89047 hasResults: False |
<|newrecord|> nctId: NCT06260072 id: IRB-HSR 21920 briefTitle: Magnesium and Riboflavin Treatment for Post-Concussion Headache overallStatus: RECRUITING date: 2020-02-10 date: 2024-12-31 date: 2024-12-31 date: 2024-02-15 date: 2024-02-16 name: University of Virginia class: OTHER briefSummary: This clinical trial will try to determine if the supplements magnesium and riboflavin will reduce the pain and duration of headaches in persons diagnosed with a concussion. The participant will be randomized to either active magnesium and riboflavin capsules or placebo (inert) capsules. The capsules will be taken once a day for 14 days. The participant will also complete a short diary form for the 14 days and will have 3 follow up visits either by telephone or in person. conditions: Concussion, Intermediate studyType: INTERVENTIONAL phases: PHASE2 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: TRIPLE whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR count: 108 type: ESTIMATED name: magnesium and riboflavin supplement measure: Headache Intensity and Duration sex: ALL minimumAge: 18 Years maximumAge: 40 Years stdAges: ADULT facility: University of Virginia Student Health and Wellness Center status: RECRUITING city: Charlottesville state: Virginia zip: 22903 country: United States name: Karen Ahern, BSN MBA role: CONTACT phone: 434-924-1549 email: kaa7p@virginia.edu lat: 38.02931 lon: -78.47668 hasResults: False |
<|newrecord|> nctId: NCT06260059 id: STUDY23070148 id: Pitt2024 type: OTHER_GRANT domain: Pittsburgh Foundation briefTitle: Efficacy Of Sodium Glucose Transporter Inhibitor (SGLT2I) In Adult Patients With Congenital Heart Disease acronym: EmpaCHD overallStatus: NOT_YET_RECRUITING date: 2024-02 date: 2026-12-31 date: 2027-06-01 date: 2024-02-15 date: 2024-02-15 name: Anita Saraf class: OTHER name: The Pittsburgh Foundation briefSummary: The goal of the study is to investigate the feasibility and benefit of novel guideline-directed heart failure therapy drug Empagliflozin (Jardiance) for adult patients with congenital heart disease (ACHD). conditions: Adult Congenital Heart Disease conditions: Heart Failure studyType: INTERVENTIONAL phases: PHASE4 allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Group 1: Empagliflozin 10 MG daily Group 2: Placebo primaryPurpose: TREATMENT masking: QUADRUPLE whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 40 type: ESTIMATED name: Empagliflozin 10 MG name: Placebo measure: Change in Ejection fraction (EF) measure: Change in Myocardial characteristics (T1 mapping of cMRI) measure: Change in Myocardial characteristics (Global strain on MRI) measure: Change in Myocardial characteristics (Global strain on echocardiogram) measure: Change in functional exercise capacity of participants. measure: Number of Participants Hospitalized for Cardiac Reasons or heart transplantation measure: Number of Deaths measure: Change in inflammatory serum biomarkers measure: Change in functional Neuropsychological Testing measure: Change in New York Heart Association (NYHA) Class measure: Change Patient-Reported Outcomes Measurement Information System (PROMIS) measure: Change in Kansas City Cardiomyopathy (KCCQ) measure: Change in Neuro-QOL sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Magee Women's Hospital city: Pittsburgh state: Pennsylvania zip: 15213 country: United States lat: 40.44062 lon: -79.99589 facility: Presbyterian Hospital city: Pittsburgh state: Pennsylvania zip: 15213 country: United States lat: 40.44062 lon: -79.99589 facility: Children's Hospital of Pittsburgh city: Pittsburgh state: Pennsylvania zip: 15224 country: United States lat: 40.44062 lon: -79.99589 hasResults: False |
<|newrecord|> nctId: NCT06260046 id: Robot Nx-SFTN briefTitle: Effect of Sufentanil on the Postoperative Pain overallStatus: NOT_YET_RECRUITING date: 2024-03-01 date: 2025-01-15 date: 2027-01-15 date: 2024-02-15 date: 2024-02-15 name: Seoul National University Hospital class: OTHER briefSummary: This study is a randomized, controlled trial. A total of 48 patients will be randomized to receive sufentanil or remifentanil during robot-assisted nephrectomy surgery. conditions: Postoperative Pain, Acute studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: PREVENTION masking: DOUBLE whoMasked: PARTICIPANT whoMasked: OUTCOMES_ASSESSOR count: 48 type: ESTIMATED name: Sufentanil name: Remifentanil measure: opioid consumption measure: Richmond Agitation-Sedation scale measure: Incidence of postoperative nausea and vomiting measure: Number of patients who administered antiemetics measure: Pain score sex: ALL minimumAge: 19 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Seoul National University Bundang Hospital city: Seongnam country: Korea, Republic of name: Chang-Hoon Koo role: CONTACT email: vollock9@gmail.com lat: 37.43861 lon: 127.13778 hasResults: False |